Lawrence Fong, MD
Columbia University, New York, NY, BA, 1984-1988, Pre-Med., Economics
Stanford University, Stanford, CA, MD, 1988-1992
Intern in Internal Medicine, University of Washington Medical Center, 1992-1993
Resident in Internal Medicine, University of Washington Medical Center, 1993-1994
Fellow in Medical Oncology, Stanford University School of Medicine, 1994-1997
Post-Doctoral Fellow, Department of Pathology, Stanford University School of Medicine. Mentor: Edgar Engleman, MD, 1996-2001
Dr. Fong is an Associate Professor, Department of Medicine (Hematology/Oncology), UCSF. Dr. Fong’s primary area of interest in research is developing novel immunotherapies for disease. More specifically he studies the effects of different treatments on the immune system. His clinical interest lies in immunotherapy of disease.
Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial.